EPIC Program Annual Data Tables 2003-2004: Table VII
| Therapeutic Class** | Number of Claims | Percent of Claims | EPIC Payments | Number of Participants |
|---|---|---|---|---|
| Total*** | 4,659,168 | 43.24% | $288,662,565 | |
| BETA ADRENERGIC BLOCKG AGENTS | 776,695 | 7.20% | $20,403,476 | 140,861 |
| DIURETICS | 643,824 | 5.98% | $5,114,548 | 135,040 |
| HMG-COA REDUCTASE INHIBITORS | 620,620 | 5.76% | $84,363,895 | 137,585 |
| ANGIOTENSIN-CONV ENZYME INH | 588,851 | 5.47% | $21,822,011 | 108,910 |
| ANTIDEPRESSANTS | 370,063 | 3.43% | $26,635,809 | 69,005 |
| PROTON-PUMP INHIBITORS | 363,961 | 3.38% | $64,433,717 | 86,385 |
| BENZODIAZEPINES (ANXIOLYTIC) | 360,656 | 3.35% | $25,734,196 | 73,169 |
| OPIATE AGONISTS | 321,452 | 2.98% | $13,409,645 | 83,469 |
| THYROID AGENTS/HORMONES | 307,763 | 2.86% | $4,481,913 | 56,551 |
| ANGIOTENSIN II RECEPTOR ANTAG | 305,283 | 2.83% | $22,263,355 | 63,756 |
*Table VII provides the percent of adjudicated claims for the program year (October 1, 2003 through September 30, 2004) as they fall into particular categories of Therapeutic Class.
** American Hospital Formulary Service® (AHFS) Pharmacologic-Therapeutic Classification.
*** This report contains the top ten drug classes; additional drug classes comprise the remainder of claims up to 100.00%.
